Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Mouse Anti-Cytokeratin 8-UNLB (SB37b)

Cat. No.:
Purified Anti-Cytokeratin 8 antibody for use in flow cytometry, immunohistochemistry / immunocytochemistry, western blot, ELISA, and immunoprecipitation assays.
Size Price (USD) Quantity
0.1 mg $185.00
More Information
Clone SB37b
Isotype Mouse (BALB/c) IgG2aκ
Isotype Control Mouse IgG2a-UNLB (HOPC-1)
Specificity Cytokeratin 8
Alternative Names CK 8, keratin 8
Description Keratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I keratin (keratins 9 to 23) and one type II keratin (keratins 1-8). The two keratin types share only 30% sequence homology. Keratins demonstrate tissue- and differentiation-specific expression profiles. Cytokeratin 8 belongs to the type B (basic) subfamily of keratins and exists in combination with keratin 18. It is expressed in all simple type epithelia tissues (e.g., liver, pancreas, kidney, gut epithelial lining) but not in stratified squamous epithelia. Cytokeratin 8 is also present in the majority of adenocarcinomas and ductal carcinomas but is absent in most squamous cell carcinomas.
Immunogen Recombinant C-terminal cytokeratin 8
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Monoclonal
Concentration 0.1 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications Immunocytochemistry – Quality tested 1
ELISA – Quality tested
Immunohistochemistry-Paraffin Sections – Reported in literature 2
Flow Cytometry 3
Western Blot 3
Immunoprecipitation 3

RRID Number AB_2794110
Gene ID 3856 (Human)
16691 (Mouse)
Gene ID Symbol KRT8 (Human)
Krt8 (Mouse)
Gene ID Aliases CARD2; CK-8; CK8; CYK8; K2C8; K8; KO K8; Card2; EndoA; Krt2-8; Krt-2.8; AA960620; AL022697; AU019895
UniProt ID P05787 (Human)
P11679 (Mouse)
UniProt Name K2C8_HUMAN (Human)
K2C8_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Chatin B, Mével M, Devallière J, Dallet L, Haudebourg T, Peuziat P, et al. Liposome-based formulation for intracellular delivery of functional proteins. Mol Ther Nucleic Acids. 2015;4:e244. (ICC)
  2. 2. Wang D. Individualized cardiovascular medicine: identifying new mechanisms to inhibit the development of myointimal hyperplasia [dissertation]. Hamburg (Germany): University Medical Center Hamburg-Eppendorf; 2015. (IHC-PS)
  3. 3. SouthernBiotech unpublished data (FC, WB, IP)